Advertisement

SUMMARY

For full details, see the 12-page conference brochure http://www.hhv-6conference.com/pdfs/HHV6SatBroch08.pdf.

Purpose: To share current evidence for the role of viral infectious agents in at least a subset of Chronic Fatigue Syndrome: covering the molecular biology, pathogenesis, diagnosis, antiviral therapy, prophylaxis of these infections.

Target audience: “Clinicians and scientists who study the role of viruses in chronic fatigue, post-infective fatigue, and central nervous system dysfunction.” Registration: ASAP, at http://www.hhv-6conference.com/satellite & see forms in brochure.

PRESENTATIONS

HHV-6 & CFS

Anthony Komaroff, MD (Harvard Medical School, Boston) - Overview on HHV-6 & CFS

Kazuhiro Kondo MD, PhD (Jikei University School of Medicine, Tokyo) - Identification of novel HHV-6 neurovirulent latent protein that causes mood disorders in CFS, psychosis and HHV-6 encephalopathy

Jose G. Montoya, MD (Stanford University, California) - Antiviral treatment of CFS patients with elevated antibodies to HHV-6 & EBV

CHRONIC EBV & CFS

Barbara Savoldo, MD (Baylor College of Medicine, Houston, Texas) - Chronic EBV, fatigue and immunotherapy by cytotoxic T-cell lymphocyte infusion

Marshall Williams, PhD (Ohio State University) - EBV DUTPase in CFS and sickness behavior

Brigitte Huber, PhD (Tufts University, Boston) - EBV and interferon activation of retrovirus K-18 in CFS

ENTEROVIRUS & CFS

Nora Chapman, PhD (University of Nebraska, Omaha) - Overview of enterovirus infections and diagnostic testing

John Chia, MD (UCLA School of Medicine, California) - Enterovirus infections in CFS

PARVOVIRUS & CFS

Mariko Seishima, MD (Ogaki Municipal Hospital, Japan) - Elevated Parvovirus antibodies and complement in CFS

Dirk Lassner, PhD (Charite-Universitatsmedizin, Berlin) – Could subset of CFS patients in fact have subclinical viral myocarditis?

BORNA VIRUS & CFS

Liv Bode, PhD (Robert Koch Institute, Berlin) - Human Borna virus infections: a possible role in chronic fatigue syndrome?

Keizo Tomonaga, DVM, PhD (Oska Unviersity, Japan) - Borna Virus antibodies in CFS patients vs. controls

IMUNOLOGICAL MARKERS & INFECTION IN CFS

Nancy Klimas, MD (University of Miami, Florida) - Immune markers in viral illness and CFS

POST-VIRAL FATIGUE: PROSPECTIVE STUDIES

Peter White, MD (Queen Mary School of Medicine, London) - Overview on Post-Viral Fatigue

Andrew Lloyd, MD (University of New South Wales, Australia) - Post-viral fatigue after acute infections

Ute Vollmer-Conna, BSc, PhD (University of New South Wales, Australia) - Cytokines in post-viral fatigue

MICROARRAY STUDIES

Jonthan Kerr MD, PhD (St. George’s University of London) - Gene expression subtypes in patients with CFS and ME

Suzanne Vernon PhD (CFIDS Association of America) - Host genetics and viral infection

TWIN STUDIES ON VIRUSES IN CFS

Birgitta Evengard MD, PhD (Umea University, Sweden) - Viral markers in Swedish twins discordant for CFS

CLINICIAN FORUM: TREATING CFS PATIENTS WITH ANTIVIRALS

Dan Peterson, MD (Sierra Nevada Internal Medicine, Incline Village, Nevada) - Antiviral treatment of patients with HHV-6, EBV & Enterovirus: Case reports

Kenny De Meirleir MD, PhD (Himmunitas Foundation, Belgium) - RNaseL activity: correlation to viral infection in CFS and viral infections

Martin Lerner, MD (William Beaumont Hospital, Michigan) - EBV & CMV in CFS and cardiomyopath